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A novel community-based study to address
disparities in hypertension and colorectal cancer:
a study protocol for a randomized control trial
Joseph Ravenell1*, Hayley Thompson2, Helen Cole3, Jordan Plumhoff4, Gia Cobb5, Lola Afolabi6,
Carla Boutin-Foster7, Martin Wells8, Marian Scott9 and Gbenga Ogedegbe10
Abstract
Background: Black men have the greatest burden of premature death and disability from hypertension (HTN) in
the United States, and the highest incidence and mortality from colorectal cancer (CRC). While several clinical trials
have reported beneficial effects of lifestyle changes on blood pressure (BP) reduction, and improved CRC screening
with patient navigation (PN), the effectiveness of these approaches in community-based settings remains
understudied, particularly among Black men.
Methods/design: MISTER B is a two-parallel-arm randomized controlled trial that will compare the effect of a
motivational interviewing tailored lifestyle intervention (MINT) versus a culturally targeted PN intervention on
improvement of BP and CRC screening among black men aged ≥50 with uncontrolled HTN who are eligible for
CRC screening. Approximately 480 self-identified black men will be randomly assigned to one of the two study
conditions. This innovative research design allows each intervention to serve as the control for the other.
Specifically, the MINT arm is the control condition for the PN arm, and vice-versa. This novel, simultaneous testing
of two community-based interventions in a randomized fashion is an economical and yet rigorous strategy that
also enhances the acceptability of the project. Participants will be recruited during scheduled screening events at
barbershops in New York City. Trained research assistants will conduct the lifestyle intervention, while trained
community health workers will deliver the PN intervention. The primary outcomes will be 1) within-patient change
in systolic and diastolic BP from baseline to six months and 2) CRC screening rates at six months.
Discussion: This innovative study will provide a unique opportunity to test two interventions for two health
disparities simultaneously in community-based settings. Our study is one of the first to test culturally targeted
patient navigation for CRC screening among black men in barbershops. Thus, our study has the potential to
improve the reach of hypertension control and cancer prevention efforts within a high-risk population that is
under-represented in primary care settings.
Trial registration: ClinicalTrials.gov, NCT01092078
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Background
Black men have the greatest burden of premature death
and disability from hypertension (HTN) in the United
States [1]. A major reason for the disproportionate mor-
bidity and mortality from HTN and its complications in
black men is poor blood pressure (BP) control [2]. Im-
proving BP control leads to significant cardiovascular
risk reduction and can be achieved through interven-
tions targeted at therapeutic lifestyle changes (TLC)
[3-11]. Several clinical trials have reported beneficial ef-
fects of lifestyle changes, such as increased fruit and
vegetable intake, decreased sodium intake, increased
physical activity, increased medication adherence and
smoking cessation on BP reduction [3,7,10,12-14]. As a
result, lifestyle changes have been adopted by various
HTN treatment guidelines as a standard first-line or ad-
junctive therapeutic option [15]. Despite the proven effi-
cacy of lifestyle changes in lowering BP in academic
research settings [3-8,12,13], there is limited data on the
effectiveness of TLC interventions in community-based
settings in this high-risk population. Of hypertensive
adults in the United States, 43% are black compared to
33.9% white [16]. Black men in particular have experi-
enced higher mortality rates resulting from hypertension
when compared to white men. In 2008, the death rate
among black men from hypertension was 50.3 per
100,000 compared to 16.5 per 100,000 for white men
[16]. Increased rates of cardiovascular disease have con-
tributed to disparities in life expectancy, where life ex-
pectancy for whites exceeded that for blacks by 5.3 years
in 2003, with the lowest life expectancy experienced by
black men (69 years) [1]. While the disproportionately
high rate of hypertension-related morbidity and mortal-
ity is often addressed in the literature, the epidemic of
colorectal cancer (CRC) among black men is compara-
tively under-appreciated. Black men have the highest in-
cidence of CRC (67.2 per 100,000 compared to 56.1 per
100,000 among white men) and the highest CRC mortal-
ity (30.5 per 100,000 compared to 20.6 per 100,000
among white men) in the US [17,18], yet have signifi-
cantly lower screening rates than whites nationally [19].
One explanation for the disproportionate mortality
due to CRC may be that black men are less likely than
white men to be diagnosed at an early stage of the dis-
ease, leading to decreased survival rates [20]. Lower
rates of early stage diagnosis may be due in part to lack
of timely screening, since CRC screening leads to identi-
fication and often, curative excision of precancerous
polyps and early cancers. Current national guidelines
recommend that all adults of average CRC risk be
screened starting at age 50, with the frequency of screen-
ing varying from 1 to 10 years based on the type of
screening test used and personal and familial history.
However, black men are less likely to be screened before
the age of 65 than white men. Even in New York City,
where disparities in overall CRC screening have been re-
duced over the past decade, racial differences in age at
screening, early stage diagnosis and CRC mortality per-
sist. Thus, for black men, a focus on early CRC screen-
ing is particularly important.
Several approaches have been shown to be successful
in increasing CRC screening rates [21-23]. One such
intervention is patient navigation, defined as “assistance
offered to patients, survivors, families, and caregivers to
help them access and chart a course through the
healthcare system” and overcome barriers to healthcare
[24]. Patient navigation has demonstrated efficacy in in-
creasing CRC screening rates when delivered in
practice-based settings [24-32], particularly among mi-
nority groups. However, as with TLC for HTN control,
the effectiveness of patient navigation programs in im-
proving the CRC screening rates in black men has not
been tested in non-clinical, community-based settings.
For both hypertension and CRC, the translation of
evidence-based approaches into community-based set-
tings is necessary for reducing the noted racial dispar-
ities in hypertension-related outcomes and CRC
mortality in black men. Barbershop-based HTN out-
reach programs are becoming common nationwide, but
whether they are an effective approach for improving
HTN control among black men is unknown due to a
dearth of evaluation research. Furthermore, no known
CRC screening interventions have been tested in the
barbershop setting.
Black-owned barbershops are rapidly gaining traction
as potential community partners for health promotion
programs targeting HTN as well as diabetes, prostate
cancer and other diseases that disproportionately affect
black men [33-37]. Barbershops hold special appeal for
community-based intervention trials, as they are a cul-
tural institution that draws a large and loyal male clien-
tele and provides an open forum for discussion of
numerous topics, including health, with influential peers.
A focus on community-based settings is particularly im-
portant among black men, a group that is less likely to
access primary care health care settings [38]. The one
randomized barbershop-based hypertension trial in the
peer-reviewed literature (the BARBER-1 trial), was
promising, demonstrating that a program of continuous
BP monitoring and peer-based health messaging in a
barbershop can: (1) be implemented by lay health
workers rather than research personnel [39], and (2) im-
prove BP control in the barbershop compared to printed
educational materials [38]. Building on these promising
results, we propose that, given its historical significance
as a trusted community setting [33], the barbershop is
not only a valuable delivery channel for evidence-based
interventions for hypertension, but may be a useful
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setting to address CRC prevention as well. In this article,
we describe an innovative randomized controlled trial
that simultaneously evaluates the effectiveness of two
evidence-based interventions set in black barbershops
targeted at BP reduction and CRC screening in black
men. Utilizing a cross-randomized design, we eliminate
the need for a true control group thereby increasing
community trust for the study, given that no participant
would be left out of receiving an intervention.
The current study, the Multi-Intervention Study to
Improve CRC Screening and to Enhance Risk Reduction
in Black Men (MISTER B), advances health services re-
search in two ways: 1) by translating clinically-proven in-
terventions for two ameliorable disease conditions that
disproportionately impact a high risk population to a
culturally-important community-based setting, and 2) by
testing two community-based interventions for two dif-
ferent high-impact conditions simultaneously in a ran-
domized controlled fashion.
Study aims
The primary aim of this study is to evaluate the effect of
two interventions on BP reduction and CRC screening
among 480 self-identified black men aged ≥50 years with
uncontrolled HTN and in need of CRC screening: 1) a
lifestyle intervention delivered through telephone-based
motivational interviewing (MINT) to reduce blood pres-
sure; and 2) a culturally-tailored patient navigation (PN)
intervention delivered by community health workers to
promote CRC screening. We hypothesize that among
enrolled participants, 1) those randomized to the lifestyle
MINT intervention will have lower BP compared to
those randomized to the patient navigation intervention
at six months, and 2) those randomized to the patient
navigation intervention will have higher CRC screening
rates compared to those randomized to the lifestyle
intervention at six months.
Methods/design
Study design
MISTER B is a two-parallel-arm randomized controlled
trial that will compare the effect of a MINT lifestyle
intervention, and a culturally targeted PN intervention
on improvement of BP and CRC screening among black
men aged >50 with uncontrolled HTN who are eligible
for CRC screening (see Figure 1).
Advantages of the study design
This innovative research design will allow each interven-
tion to serve as the control for the other. Specifically,
the MINT arm will be the control condition for the PN
arm, and vice-versa, in that the MINT intervention arm
will receive usual counseling for colon cancer screening,
and the PN arm will receive usual counseling about ap-
propriate lifestyle changes to improve BP. We believe
this novel, simultaneous testing of two community-
based interventions in a randomized fashion is an eco-
nomical and yet rigorous strategy that enhances the
Men from the barbershops and community at large 
are referred to mobile van or blood pressure 
screening table
Baseline Assessment
Enroll eligible men for study
(Age 50, male, BP uncontrolled)
Randomize consenting eligible men
Ineligible
Refusals
Motivational Interviewing Lifestyle Intervention
(n = 240)
CRC Patient Navigation Intervention
(n = 240)
6-Month Assessment 6-Month Assessment
Figure 1 Study design.
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acceptability of the project to the community because all
participating men will receive a potentially beneficial
intervention (that is, no one receives a ‘placebo’. See
Figure 1). The MINT intervention will be conducted by
trained research assistants, while the PN intervention
will be delivered by trained community health workers.
Assessments are conducted at the baseline (visit 1) and
six months follow-up (visit 2).
Though we are testing interventions simultaneously
within the same trial, we do not see the interventions as
tackling BP and CRC in tandem. The intervention for BP is
distinct from the intervention for CRC, even though the in-
terventions are being tested simultaneously. If these inter-
ventions prove successful in our study, successful
translation of these interventions would not necessitate that
the BP and CRC interventions be delivered together, as they
are not delivered together in the study. The interventions
are not necessarily complementary, but were chosen be-
cause they are similarly high-impact public health problems
for black men, and are conducive to community-based de-
livery in a population that is under-represented in primary
care clinical settings.
Challenges of the study design
Given that randomization will occur at the level of the
individual, and the socially interactive nature of the re-
cruitment setting, wherein participants randomized to
different arms will presumably talk to each other, there
is potential for some between-arm contamination, which
may dampen the observable results in either arm. To ad-
dress this potential threat to the validity of the study de-
sign, we have added important safeguards to minimize
contamination. First, both the MINT and PN interven-
tions are highly tailored to address participant’s specific
concerns and barriers through individualized counseling
strategies implemented over multiple sessions. Each
intervention includes several interdependent compo-
nents, reflecting a complexity that significantly reduces
each arm’s vulnerability to contamination. These inter-
vention characteristics, along with the complexity of the
target behaviors (lifestyle changes for BP control or col-
onoscopy) make it unlikely that any exposure to activ-
ities, participants or interventionists across study arms
would have a significant effect on individual outcomes.
Second, we have employed an additional safeguard to
minimize contamination: MINT interventionists will be
trained separately from PN interventionists, and each
interventionist will be trained to do MINT only or PN
only. There will be no “cross-training”, thereby minimiz-
ing “bleed” of one intervention into another.
Eligibility criteria
Uncontrolled HTN is defined in accordance with current
consensus clinical hypertension guidelines (Seventh
Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood
Pressure (JNC-7)) as an average BP that fulfills criteria
of systolic blood pressure (SBP) ≥130 or diastolic blood
pressure (DBP) ≥80 mmHg for those with diabetes or
chronic kidney disease, and SBP ≥135 or DBP ≥85
mmHg for all others [15]. Criteria for CRC screening eli-
gibility (based on multi-society consensus guidelines) in-
clude: 1) no colonoscopy in the last 10 years; 2) no
flexible sigmoidoscopy, Digital Contrast Barium Enema
or CT-colonoscopy in the last 5 years, or 3) no Fecal Im-
munochemical Test (FIT) or Fecal Occult Blood Test
(FOBT) in the last 12 months. In order to be eligible for
the study a man must 1) self-identify as black or African
American, 2) be age 50 or over, 3) have uncontrolled
HTN, 4) be in need of CRC screening, 5) have a working
phone, and 6) be fluent in English. Participants will be
excluded if they do not meet any of these criteria. Ap-
proximately 480 self-identified black men who meet eli-
gibility criteria will be randomly assigned to one of the
two study conditions.
Ethical approval
The study has been approved by the Institutional Review
Board at New York University School of Medicine
(protocol #09-0151). The study will be monitored by a
Data Safety and Monitoring Board.
Study sites and population
MISTER-B will be conducted in black-owned barber-
shops throughout New York City. Black-owned barber-
shops are a major small business enterprise in urban
centers across the United States [33]. In Harlem alone,
there are more than 75 barbershops that cater exclu-
sively to black men. The black-owned barbershop is a
popular community site where black men of all socio-
economic strata gather frequently and feel comfortable
discussing important issues in their lives [33]. Black bar-
bers are influential peers with a long history of shaping
public opinion [33-37]. Previous studies indicate that the
average customer has had the same barber for over a
decade and visits the same barber for a haircut every
week or two [39]. Emerging evidence suggests barber-
shops constitute an existing and unique community set-
ting and peer network that can be utilized to improve
cardiovascular health and cancer prevention in the black
male community.
Study proceduresBarbershop recruitment
The recruitment process will begin with the recruitment
of barbershops to serve as recruitment sites (see
Figure 2). Barbershops will be recruited through word of
mouth and by neighborhood tour accompanied by cold
recruitment. First, neighborhoods will be identified by
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examining data from the US Census data and the New
York City Department of Health and Mental Hygiene to
determine which neighborhoods have large populations
of blacks, relatively high incidence of HTN and low rates
of timely screening colonoscopy. Staff experience with
neighborhoods in New York City and knowledge of traf-
fic patterns in various business districts will also inform
where site recruitment is conducted. As more shops are
recruited, barbershop referrals from participants, study
investigators and barbershop owners will also be
approached. For each shop, the study staff will discuss
the study with the shop owner or manager and present a
written description of study procedures, benefits and ex-
pectations. If the shop is interested in participating, the
staff and the shop will set up a mutually agreeable time
to do an eligibility screening event for the study. Leading
up to the eligibility screening, the study staff will work
with the owner or manager to advertise in the neighbor-
hood by distributing flyers about the study.
Participant recruitment and eligibility screening
Participants will be recruited from barbershops that have
agreed to participate in the study. For this purpose, we
will park an all-purpose mobile health van at the barber-
shop storefronts. The van is part of an existing commu-
nity health promotion program directed by one of the
investigators (MS). When the van is not available, we
will set up our blood pressure monitors inside the
barbershop. Barbers in the participating barbershops will
refer potentially eligible customers to the van or to our
table. Once a potential participant is referred, the re-
search assistant (RA) will approach him to complete the
eligibility screen. As part of the screening, the RA will
assess need for CRC screening in each participant, de-
fined as not having 1) a colonoscopy in the last 10 years;
2) flexible sigmoidoscopy, digital contrast barium enema
or CT-colonoscopy in the last five years, or 3) FIT or
FOBT in the last 12 months. Blood pressure will be
measured three times as per the American Heart Associ-
ation measurement protocol with a validated automatic
oscillometric BP monitor, and the average reading will
be considered to determine study eligibility. Only those
men that meet the eligibility criteria will be invited to
participate in the study.
Informed consent process
A waiver of signed informed consent was obtained from
the IRB for the screening portion of the recruitment
process as no identifiable personal health information
will be collected for screening purposes. Recruitment
staff will acquire verbal informed consent from the par-
ticipants prior to screening for eligibility. For each eli-
gible participant who decides to enroll in the study,
recruitment staff will obtain written informed consent.
Data collection
Immediately following the consent process, eligible par-
ticipants will complete the baseline data collection
process which will include a 30- to 45-minute structured
interview. The interview will be conducted by trained re-
search assistants, data will be recorded on interview
forms, and the interviews will be audio-recorded for fi-
delity. The baseline interview will consist of structured
questions and questionnaires on demographics, psycho-
social characteristics, such as self-efficacy and attitudes
toward CRC screening comorbidity, and self-reported
Figure 2 Study procedures.
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behaviors associated with the primary and secondary
outcomes. See Table 1 for a complete list of study mea-
sures. All data will be collected at the barbershop at the
time of recruitment. If the participant does not have
time to complete all study procedures, an appointment
will be made within two weeks of recruitment to
complete the remaining procedures. Participants will
also be offered the possibility of coming to the study of-
fice to complete data collection if it is more convenient
for the participant. Follow-up data will be collected six
months after each participant is enrolled in the study.
Study staff assigned to collect data will make an appoint-
ment with each participant by telephone to meet the
study staff at the participating barbershop or to meet
study staff at the study office to complete the data col-
lection process.
Randomization
Following the determination of eligibility, consent proce-
dures, and completion of baseline self-report and psy-
chosocial measures, individual-level randomization will
occur via a randomization table generated by the study
statistician. Participants will be randomized in 1:1 ratio
to either the MINT lifestyle intervention or the CRC pa-
tient navigation intervention.
Participants will be informed of the results of
randomization by an RA at the time of the baseline
interview. At this time, the RA will discuss the MINT or
the PN intervention/counseling session schedule, and
answer any additional questions. Given the nature of the
intervention, it is impossible to blind the RAs to the
assigned condition. However, the dimension that the
RA’s knowledge of the assigned condition could possibly
affect is the BP measurement - one of the primary out-
comes of this study. To reduce the potential for this
bias, we will use an automated BP device (Vital Signs
Monitor 300 Series; Welch Allyn; Skaneateles Falls, NY,
USA). The other primary outcome, receipt of colon can-
cer screening, cannot be influenced by the RA’s know-
ledge of the assigned condition.
Participant reimbursement
Participants will receive $15 at the completion of base-
line assessment, $20 for completing the majority of the
intervention sessions and $20 at the completion of the
six-month visit ($55 total) for their time and effort in
the study. All participants will also receive free metro
cards to help facilitate transportation to and from the
study site for the six-month visit. After completing the
baseline interview, participants will also receive a
Table 1 Study measures
Measures Baseline 6 months
Physiological Measures
Blood pressure measurements X X
Height, Weight, Waist circumference, and Body Mass Index X X
Self-report Measures
Participant demographics X X
(selected questions)
Medical Comorbidity (Charlson Comorbidity Index) X X
Medication adherence (4-Item Morisky Questionnaire) X X
International Physical Activity Questionnaire (IPAQ- Short Version) X X
Diet (2-Item Food Frequency Questionnaire) X X
Intrinsic Motivation (Treatment Self-regulation Questionnaire) (Diet/Physical Activity version) X X
Self-Efficacy (Diet/Physical Activity Self-Efficacy Questionnaire) X X
Pros and Cons of Colonoscopy X X
Fear of Colonoscopy X X
Self-Efficacy Regarding CRC Screening X X
Intention and Behavioral Control X
Thompson BQ Healthcare Trust Scale X X
Assessment of CRC completion screening X
Healthy Lifesyle Changes Follow-up Questionnaire X
Decisional Regret X
Health Literacy (Newest Vital Sign) X
Intervention Satisfaction X
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voucher for a free haircut to be redeemed at a participat-
ing barbershop.
Description of the interventions
MINT lifestyle intervention
Motivational Interviewing (MINT) is an empirically
tested, client-centered counseling approach designed to
motivate people for change by helping them recognize
and resolve the discrepancy between their present be-
havior and future personal goals and values [40,41]. Sev-
eral behavioral intervention trials that have included
black men (range 12 to 35% of the study population)
[42-46], have demonstrated the potential efficacy of
MINT in this population. The content of the interven-
tion will be based on established hypertension treatment
guidelines, which recommends weight loss (if over-
weight), limiting sodium and alcohol intake, smoking
cessation, medication adherence, regular physical activity
and eating a low-fat diet that is rich in fruits and vegeta-
bles [15]. As such, all participants will be given the NIH/
NHLBI “Your Guide to Lowering Blood Pressure” booklet
as well as the NIH/NHLBI DASH diet booklet titled
“Facts about the DASH Eating Plan” and guided through
the topics by the research assistant during the baseline
session. The methodology, structure and the content of
the MINT counseling sessions will be patterned after
our recently completed and successful practice-based
trial [47].
The MINT sessions will focus on individual needs to
tailor intervention strategies to the participant’s personal
context, including social support, specific behavior change
goals, problem-solving and maintaining motivation during
challenging situations (see Table 2). The men randomized
to this group will receive four MINT sessions on lifestyle
behaviors. The first MINT session will occur in person im-
mediately after baseline data collection at the barbershop
and the subsequent three sessions will occur over the
phone. The frequency will be monthly for the first two
months and then bi-monthly for the next four months,
with each session lasting up to 30 minutes. After the intro-
ductory session, each subsequent session will include the
following steps: 1) assessing the participant’s motivation
and confidence in engaging in a given behavior - physical
activity, taking medication as prescribed, smoking cessation,
dietary restriction of sodium or increased intake of fruits
and vegetables; 2) eliciting barriers and concerns about
adoption of each lifestyle modification; 3) summarizing the
‘pros’ and ‘cons’, thereby eliciting positive self-motivational
statements about the behavior; 4) providing a menu of op-
tions; 5) assessing the participant’s values and goals in con-
nection with his current health behavior pattern; and
finally, 6) each encounter will end with a global summary
of what was discussed and clarification of an agreed upon
action plan.
Monitoring treatment fidelity for the MINT intervention
Fidelity to the intervention protocol is an important
consideration for complex interventions. Using the ex-
panded Lichenstein treatment fidelity model developed
by the OBSSR Behavior Change Consortium [48,49], we
will ensure fidelity through training and ongoing fidelity
monitoring. At the beginning of the study, research as-
sistants will participate in an intensive training that con-
sists of the basic physiology of blood pressure,
instruction on proper measurement of blood pressure, a
primer on behavioral principles of the intervention, and
basic interview skills taught through role playing and di-
dactic teaching. In addition, research assistants will re-
ceive two full days of information on the principles of
MINT techniques, and practice in the delivery of MINT
via role-playing. The interventionists will meet biweekly
to discuss the previous week’s sessions, troubleshoot,
problem-solve and plan for the following week. Bi-
monthly booster sessions will be conducted to minimize
drift in MINT counseling skills.
All individual MINT sessions will be digitally audio-
taped and used for two purposes: 1) individual counselor
development and ongoing training/supervision; and 2)
systematic review for treatment fidelity. The relatively
immediate review and use of recordings will facilitate
the feedback and coaching process to develop and main-
tain the skills of the trained counselor, an approach that
has proven to be effective in previous MINT studies
[43]. The audio files will also be archived for systematic
sampling of a third of participant’s first session and an-
other randomly selected session for adherence to MINT
principles as scored by the Motivational Interviewing
Treatment Integrity (MITI) scale [50], a validated instru-
ment with satisfactory reliability, convergent and dis-
criminative validity [51].
Patient navigation intervention
This intervention will be patterned after the standard
New York City Department of Health and Mental Hy-
giene (NYC DOHMH) patient navigation (PN) protocol
[52], and culturally-targeted to black men. It is widely
accepted in the health promotion literature that inter-
ventions are more effective when they are culturally ap-
propriate. Thus, the effect of a CRC screening
navigation intervention in black men may be improved
by enhancing its cultural appropriateness through cul-
tural targeting, defined as the use of “a single interven-
tion approach for a defined subgroup that takes into
account characteristics shared by the subgroup’s mem-
bers” [23]. This can be achieved via several approaches
[53] that are particularly relevant to CRC screening navi-
gation: 1) an evidential approach that focuses on the
impact of a given health issue on the target group
through data, including incidence, prevalence or
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mortality rates; 2) a linguistic approach that focuses on
using the preferred language of a specific group; and 3)
a sociocultural approach that addresses health-related is-
sues in the context of broader social and cultural values
and characteristics of a group. Compared to standard or
“generic” interventions, culturally targeted interventions
are rated more favorably, are perceived as more credible,
and result in greater retention of knowledge over time
and greater adherence to recommended health behaviors
[54-57].
The goals of the intervention will be to 1) educate par-
ticipants about CRC screening tests; 2) address partici-
pants’ concerns about CRC screening; and 3) help
participants overcome barriers to screening (Table 2).
Participants randomized to this arm will receive at least
two planned sessions with trained patient navigators
(PN) to assist them with completion of their choice of
CRC screening modality. The first session will occur
within seven days of enrollment, and will include
culturally-targeted education about 1) CRC in African
Americans, 2) risk factors and symptoms of CRC, 3) the
need, eligibility and timeline for CRC screening, and 4)
the different screening modalities. All participants will
be given the American Cancer Society Colon Cancer
DVD and Prevent Cancer Foundation Colon Cancer
pamphlet. According to consensus guidelines, the main
goal of CRC screening should be cancer prevention, and
thus, structural examinations like colonoscopy are the
screening tests of choice when the resources are avail-
able to an individual willing to undergo an invasive test.
If participants are unwilling to undergo an invasive test
or resources are not available, annual screening with
high-sensitivity stool-based tests, like the fecal immuno-
chemical test (FIT) card, is an acceptable option for
colorectal screening in average risk adults aged 50 years
and older [58].
Table 2 Intervention components
Motivational interviewing Patient navigation
Initial Session (in person
when possible)
Review lifestyle recommendations in the NHLBI Pamphlets. Review information in American Cancer Society and
Prevent Cancer Foundation DVD/pamphlets:
• Weight loss for those with a BMI >25 • Colorectal cancer and statistics relevant to black
men
• At least 180 min/week of physical activity • Risk factors, symptoms and healthy behaviors
• No more than 1500 mg/day of dietary sodium • CRC screening options
• 9-12 daily servings of fruits and vegetables Explore participant’s barriers (ie lack of knowledge,
beliefs and attitudes, fear, logistics) and commitment
to CRC screening.• 2-3 servings of low fat dairy product
• Intake of total fat/saturated fat of < 25% and 75% of total
calories respectively
Plan follow-up sessions, colonoscopy referral and/or
FIT mailing.
• Smoking cessation
• Medication adherence
Barriers to the adoption of TLC are explored and initial goal
set.
Follow-Up/Maintenance
Phase (via phone, 30
minutes per session)
1) Assess participant’s motivation and confidence in engaging
in given lifestyle behavior
Utilize CEEP (Clarify-Empathize-Explain-Plan)
counseling during weekly sessions to assist
participants in:
2) Elicit barriers and concerns about adoption of each lifestyle
modification
• Overcoming barriers to CRC screening
3) Summarize in a non-threatening manner the ‘pros’ and
‘cons’ of participant’s concerns, thereby eliciting positive self-
motivational statements about the behavior
• Obtaining colonoscopy referrals or FIT card
4) Provide a menu of options to the participant based on the
nature of barriers elicited from him
• Scheduling and attending appointments
5) Assess participant’s values and goals, in order to help him
link his current health behavior pattern to his core values and
life goals
• Purchasing bowel preparation prescription
6) Global summary of what was discussed and clarification of
an agreed upon action plan
• Completing bowel preparation or FIT testing steps
• Securing appointment escort
• Troubleshooting insurance issues
• Understanding CRC screening results
• Completing treatment follow-up for positive results
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The initial session will primarily address the financial,
structural and psychological barriers to CRC screening
completion. After assessing the participant’s commit-
ment to CRC screening, the navigator will refer the par-
ticipant to the appropriate hospital, and/or will review
the FIT completion process and mail three-day
Hemoccult® ICT cards to those who request them. The
navigator will encourage participants to schedule their
colonoscopy appointment within one month or to return
the completed FIT cards for testing within two weeks. In
the case of colonoscopy, the second session will occur
one week before the scheduled appointment, during
which the navigator will review bowel preparation infor-
mation and discuss potential barriers to attending the
colonoscopy appointment (that is, obtaining the bowel
prep or securing an escort, a requirement for discharge
at many medical centers). In the case of FIT, the naviga-
tor will call participants to confirm receipt of the FIT
card and review the testing steps. A third session might
be necessary to confirm colonoscopy completion or relay
FIT card results. In the case of multiple participant bar-
riers, the navigator will continue to contact the partici-
pant on a weekly basis throughout the six-month
intervention until the barriers are resolved and CRC
screening is completed.
Monitoring fidelity for the patient navigation intervention
As with the treatment fidelity outlined above for the life-
style intervention, we will adopt the Behavior Change
Consortium Treatment Implementation model [48,49].
The patient navigation coordinator for the research team
(someone with extensive case management experience)
and a co-investigator (Dr. Thompson) will conduct in-
tensive navigator training over the course of two days,
utilizing the Colonoscopy Patient Navigator Program
Orientation Manual training manual from the New York
City Department of Health (NYC DOHMH) Program
for Cancer Prevention and Control [52]. The main train-
ing goals will be: 1) education (colon cancer, statistics,
CRC screening) and 2) outlining the role of patient navi-
gators (appointment referrals and reminders).
The NYC DOHMH modules will be supplemented
with strategies to culturally target the navigation proto-
col to black men. This component includes 1) an over-
view of CRC statistics specific to black men; 2) a review
of known barriers to CRC screening in black adults; 3)
application of the CEEP barrier counseling framework
(Clarify-Empathize-Explain-Plan) used in previous work
[59]; 4) interactive exercises to increase proficiency; and
5) a review of intervention protocol and data collection
procedures. Each navigator will also participate in a
minimum of three individual, one-on-one skill-building
sessions to increase their confidence and mastery; three
hours of role plays to simulate realistic PN experiences;
a minimum of two hours’ training on intervention docu-
mentation and database usage; and at least three hours
of one-on-one follow-up training with the patient navi-
gator coordinator. Finally, patient navigators will under-
take 56 hours of formal community health worker
training organized by the Community Health Worker
Network of New York City.
All navigation sessions will be digitally audio-recorded
and used for two related purposes: 1) ongoing training/
supervision of navigators; and 2) review for treatment fi-
delity. Ten percent of recorded navigation sessions will
be randomly selected and reviewed by the PN expert
using a PN fidelity checklist adapted from the Patient
Navigator Performance Checklist [60] and informed by
the Technology Model of intervention integrity monitor-
ing [61] If this review reveals drift in the intervention
delivery protocol by navigators, individual training ses-
sions will be conducted to review relevant areas of train-
ing and refine navigator skills through role-play and
feedback.
Outcome assessments
The primary outcomes will be 1) within-patient change
in systolic and diastolic BP from baseline to six months
and 2) CRC screening rates as determined by colonos-
copy report from the primary care provider at six
months. For a complete list of measures, please refer to
Table 1.
Primary outcomes
Blood pressure
At eligibility screening and six-month follow-up visits,
three BP measurements will be taken by a trained RA
using an automated BP monitor (Vital Signs Monitor
300 Series; Welch Allyn) following AHA guidelines [62].
The average of the three readings will be used as the
measurement for each visit. Uncontrolled BP as defined
by the JNC-7 criteria is SBP ≥135 mm Hg or DBP ≥85
mm Hg, with lower thresholds of SBP ≥130 or DBP ≥80
applied to those with co-morbid diabetes or kidney dis-
ease [15].
CRC screening
CRC screening will be measured primarily by self-report.
At six-month follow-up, participants will be asked
whether they had a colonoscopy or any other screening
for colorectal cancer during the course of the study. As
the study will be based in the community and not dir-
ectly related to any specific CRC screening program,
participants who report having had CRC screening and
records of it will be requested from the health center.
Participants will be asked to sign a medical release form
at the time of informed consent to grant permission to
the research team to obtain CRC screening reports.
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Secondary outcomes
Fruit and vegetable intake will be measured at baseline
and six-month follow-up using a two-item questionnaire
developed and validated by Resnicow and colleagues
[44]. The items ask how many servings of fruits and veg-
etables participants eat on an average day.
Physical activity will be measured using the short ver-
sion of the International Physical Activity Questionnaire
(IPAQ-S). The IPAQ-S is a self-report measure that as-
sesses moderate- and vigorous-physical activity, walking,
and time spent sitting over a seven-day period. A score
is calculated by multiplying the hours and minutes per
day spent doing each type of activity by the average
metabolic equivalent (MET) and adding each category to
the total.
Height, weight and waist circumference will be mea-
sured using a stadiometer, with a validated scale (HD-351
Digital Weight Scale; Tanita Corporation of America,
Inc.; Arlington Heights, IL, USA), and using a cloth
measuring tape, respectively, after the participant has
taken off heavy outer garments. All measurements will
be recorded to the nearest cm and kg. Height and weight
will be used to calculate the body mass index (BMI) for
each participant. The difference in weight and waist cir-
cumference from baseline to six-month follow-up will be
used as a measure of weight-loss over the course of the
study. Height will only be measured at baseline.
Analysis
Sample size and power calculations
The sample size is based on the number of participants
needed to provide adequate power to test the primary
hypothesis, that is, to detect the hypothesized group dif-
ferences in the primary outcomes. Based on our own
clinical experience and estimates from other clinical tri-
als in uncontrolled hypertensive patients [4-6,11,63] we
estimate that the cross-sectional standard deviations
(SD) of SBP and DBP at baseline will be about 15/12
mm Hg. Conservatively, assuming (a) that the SD at
follow-up will be 25% larger in the MINT group, (b) that
the correlation between baseline and follow-up BPs will
be 0.6 in the CRC patient navigation group and 0.4 in
the MINT group (both due to heterogeneity of treatment
response), and (c) that there are no barbershop effects
(as this is an individual level intervention) on the change
in BP, 200 participants per group will provide 86% power
to detect a 5 mmHg differential change in SBP and the
same power to detect a 4 mmHg differential change in
DBP, based on testing the Time X Group interaction in a
MANOVA, allowing for heterogeneous variances and
serial correlations [64]. Regarding the CRC navigation
arm, a sample size of 127 participants per group is
needed to provide 90% power to detect a group differ-
ence in the rate of completed CRC screening at six
months from a baseline rate of 35% [26,27,32,65] to a
desired level of 60%. Consequently, we will recruit 240
participants per intervention group (allowing for 20% at-
trition), which will provide sufficient power to detect the
hypothesized difference in both arms of the study. Power
analyses were conducted using the R statistical language
[64,66].
Analysis of the primary aims
Blood pressure
MANOVA will be used to test the hypothesis that those
assigned to MINT counseling will, on average, exhibit
greater six-month decreases in SBP and DBP than those
assigned to the CRC patient navigation condition. This
analysis will have one within-person factor - Time (base-
line vs. six-month follow-up) - and one primary
between-persons factor (Treatment Group). The out-
come measure in this analysis will comprise a linear
combination of systolic and diastolic BP.
Colon cancer screening
Logistic-type regression will be used to test the hypoth-
esis that those assigned to patient navigation interven-
tion will have significantly higher CRC screening rates
compared to those randomized to the lifestyle interven-
tion at six months. Clustered sampling effects due to site
and physician will be incorporated using a multilevel
modeling approach.
Discussion
Public health significance and implications for future
research
This protocol will be a unique opportunity to test two
interventions simultaneously, offering at least one inter-
vention to each study participant regardless of random-
ized assignment, eliminating the need for a traditional
control group and accompanying ethical issues. Our
study will be one of the first to test patient navigation
for CRC screening in a community-based setting, thus
having the potential to reach individuals without access
to regular primary care. These individuals, who are
underserved by the healthcare system, are in greater
need for preventive care than those with a regular source
of primary care and are generally overlooked in clinic-
based studies.
Future research should test other innovative methods
of addressing health disparities among true community-
based populations. Furthermore, our study addresses
two health issues among urban black men, yet more re-
search is needed to determine whether there are import-
ant differences produced by ethnicity or socioeconomic
status within this diverse demographic which may de-
serve further attention. Finally, it is important to main-
tain effective programs past the length of a randomized
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control trial, thereby maintaining the trust of communi-
ties and continuing to address health disparities beyond
the scope of individual research studies. Research into
the efficacy of developing sustainable methods to ad-
dress health disparities in black communities is essential.
Trial status
The Mister B trial began recruitment in December of
2009. To date, we have recruited a total of 444 partici-
pants from 103 barbershops and other community orga-
nizations. Of those, 219 are randomized to receive the
MINT intervention, 225 are randomized to receive the
PN intervention. Participant recruitment will conclude
in approximately four months, and participants will be
followed for six months.
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